secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORTHOPEDIATRICS CORP (KIDS)
CIK:        0001425450
Form:       8-K
Filed at:   2026-08-04T20:08:24+00:00
Accession:  0001425450-26-000066
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OrthoPediatrics Q2 revenue $70.5M (+15% YoY), raises FY2026 guidance to $265-269M
--------------------------------------------------------------------------------

- Q2 2026 revenue $70.5M, up 15% YoY; domestic +14%, international +22%.
- Trauma & Deformity revenue $52.6M (+26% YoY); Scoliosis $16.9M (-9% YoY).
- Net loss $7.2M ($0.30/share); adjusted EBITDA $6.8M vs $4.1M YoY.
- Free cash flow usage improved 78% to $3.1M; cash $47.9M at quarter end.
- Raised FY2026 revenue guidance to $265-269M; expects breakeven FCF in 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425450/000142545026000066/0001425450-26-000066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425450/000142545026000066/kids-20260804.htm
  HTML page:      https://secwatch.observer/filing/0001425450-26-000066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer